ILC Dover’s Life Sciences Solutions Your Process. Our Priority

Featured Therapeutic Markets (ADC & GLP-1)

ILC Dover delivers advanced containment and single‑use solutions for today’s most innovative therapeutic markets, including GLP‑1 therapies, antibody–drug conjugates (ADCs), cell & gene therapy, biologics, and small molecule manufacturing. Our solutions are engineered to address high‑potency handling, contamination control, and regulatory compliance—supporting safe, efficient, and scalable operations from development through commercialization.

With decades of expertise and cutting‑edge technology, ILC Dover helps manufacturers accelerate time‑to‑market, protect personnel and products, and maintain uncompromising quality.

ILC Dover — your partner in advancing modern therapeutic manufacturing.

Our solutions are distinguished by superior consistency and conformance, driven by an efficient business management system that oversees operations for consistency and excellence. Each component undergoes construction and inspection in ISO-certified facilities, employing validated methods to meet rigorous quality standards prior to delivery to your facility.

ILC Dover is hiring as we continue to meet increased demand within the life sciences and aerospace industries. Join our team to go beyond boundaries.